ArticleFrontiers in genetics2020

CD52 Is a Prognostic Biomarker and Associated With Tumor Microenvironment in Breast Cancer.

Jianxin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.